Cocrystal Pharma Corp - COCP Net Assets per Single Share

Cocrystal Pharma, Inc. (COCP) relies on a loyal staff of highly specialized experts, securing talent through stock options. An academic approach and a focus on patents attract leading biologists to the company. However, fierce competition for market attention creates risks when facing global behemoths. The book value per common share illustrates the dynamics of net assets, where 0.08 serves as the current value of the parameter.

Cocrystal Pharma Inc (COCP): Share Book Value from 07/04/2022 to 10/27/2026

cocrystalpharma.com - analytical breakdowns and key metrics (COCP)

- price and consensus price forecast:

Stock Price Cocrystal|COCP - Consensus Target

- market capitalization data:

Market Value Cocrystal Pharma, Inc.|COCP - Full Business Value

- book capitalization data:

Net Assets per Single Share Cocrystal Pharma|COCP - Net Asset Value|Market Capitalization to Book Value Ratio cocrystalpharma.com|COCP - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Cocrystal Pharma, Inc.|COCP - Long-Term Debt to Capital|Short-Term Debt to Equity Cocrystal Pharma|COCP - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Cocrystal Pharma, Inc.

Fundamental company valuation:Cocrystal - COCP

Manufactured products of Cocrystal Pharma

Book value per share determines the portion of net assets attributable to a single security, allowing an investor to assess the intrinsic value of the business relative to market quotes. The current BVPS of 0.08 reflects the capital reserve of Cocrystal Pharma, Inc. (COCP) for funding early-stage clinical trials amid fierce competition for investment with other biotech startups.

Competitors of Cocrystal Pharma, Inc. (COCP)

GILD: Book Value per Share|CDTX: Accounting Value per Share|Net Assets per Single Share Novavax, Inc. (NVAX)|CVAC (curevac.com) - Share Book Value|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|Invivyd Inc - Book Value per Share|Net Assets per Single Share Enanta Pharmaceuticals, Inc. (ENTA)|INO: Accounting Value of a Share|HLVX (HilleVax Corp) - Net Assets per Single Share|Kalaris Tx (KLRS) - Accounting Value per Share|DYAI (Dyadic International Inc) - Book Value per Share|Book Value per Share NanoViricides Corp (NNVC)|Talphera (TLPH) - Accounting Value per Share|Accounting Value of a Share trawspharma.com TRAW|Accounting Value per Share Dogwood Therapeutics DWTX|Net Assets per Single Share Qualigen Corp QLGN|Book Value per Share ALVR (AlloVir Bio)|VBIV: Net Assets per Share|Net Assets per Single Share virios.com VIRI|Accounting Value of a Share Vaxart